Avoid common mistakes on your manuscript.
To the Editor: As originally postulated by Harold Himsworth [1], a reduction in insulin sensitivity in muscle is associated with an increased risk of human type 2 diabetes. Thus, the finding that downregulation of caveolin-1 production leads to a reduction in insulin resistance, which is improved by upregulation of production of this protein as described by Oh et al. [2], is of considerable interest. Appropriate modulation of caveolin-1 production might be expected to be of benefit for reduction of the risk of type 2 diabetes in humans.
Hypovitaminosis D has been shown to be associated ‘dose-wise’ with lower insulin sensitivity in humans in cross-sectional studies [3, 4]; it is also associated with an increased risk of type 2 diabetes both cross-sectionally and prospectively in humans [5–7]. Caveolin-1 protein is necessary for the rapid non-genomic actions of activated vitamin D [8]. Adequate vitamin D repletion may contribute, therefore, to the maintenance of insulin sensitivity in humans through caveolin-1 modulation. This possibility is supported by the finding of marked insulin resistance and vitamin D resistance in humans with Berardinelli–Seip congenital lipodystrophy, who have a homozygous nonsense caveolin-1 mutation [9]. It would, therefore, be of great interest to know whether activated vitamin D improves insulin sensitivity in the JYD mouse (an ageing-dependent non-obese animal model of type 2 diabetes) of Oh et al. [2] and, if so, whether this might be caused by upregulation of caveolin-1 production.
References
Himsworth HP (1949) The syndrome of diabetes mellitus and its causes. Lancet 19:465–473
Oh YS, Khil L-Y, Cho KA et al (2008) A potential role for skeletal muscle caveolin-1 as an insulin sensitivity modulator in ageing-dependent non-obese type 2 diabetes: studies in a new mouse model. Diabetologia 51:1025–1034
Baynes KC, Boucher BJ, Feskens EJ, Kromhout D (1997) Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 40:344–347
Chiu KC, Chu A, Go VL, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79:820–825
Hyppönen E, Boucher BJ, Berry DJ, Power C (2008) 25 hydroxyvitamin D, IGF-1 and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 57:298–305
Forouhi NG, Luan J, Cooper A et al (2008) Baseline serum 25-hydroxyvitamin D is predictive of future glycaemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes 57:2619–2625
Knekt P, Laaksonen M, Mattila C et al (2008) Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 19:666–671
Huhtakangas JA, Olivera CJ, Bishop JE et al (2004) The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha, 25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 18:2660–2671
Kim CA, Delépine M, Boutet E et al (2008) Association of a homozygous nonsense caveolin-1 mutation with Berardinelli–Seip congenital lipodystrophy. J Clin Endocrinol Metab 93:1129–1134
Duality of interest
The author states that there is no duality of interest associated with this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boucher, B.J. Does vitamin D status contribute to caveolin-1-mediated insulin sensitivity in skeletal muscle?. Diabetologia 52, 2240 (2009). https://doi.org/10.1007/s00125-009-1478-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-009-1478-5